DE602005026225D1 - Sterilisationsprozess für Steroide - Google Patents

Sterilisationsprozess für Steroide

Info

Publication number
DE602005026225D1
DE602005026225D1 DE602005026225T DE602005026225T DE602005026225D1 DE 602005026225 D1 DE602005026225 D1 DE 602005026225D1 DE 602005026225 T DE602005026225 T DE 602005026225T DE 602005026225 T DE602005026225 T DE 602005026225T DE 602005026225 D1 DE602005026225 D1 DE 602005026225D1
Authority
DE
Germany
Prior art keywords
steroids
sterilization process
steroid
excipient
wet mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005026225T
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of DE602005026225D1 publication Critical patent/DE602005026225D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE602005026225T 2004-03-12 2005-03-11 Sterilisationsprozess für Steroide Active DE602005026225D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN313MU2004 2004-03-12

Publications (1)

Publication Number Publication Date
DE602005026225D1 true DE602005026225D1 (de) 2011-03-24

Family

ID=34814930

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005026225T Active DE602005026225D1 (de) 2004-03-12 2005-03-11 Sterilisationsprozess für Steroide

Country Status (4)

Country Link
US (1) US7892483B2 (de)
EP (1) EP1574222B1 (de)
AT (1) ATE497787T1 (de)
DE (1) DE602005026225D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
EP1782839A1 (de) * 2005-11-03 2007-05-09 Genetic S.p.A. Verfahren zur Sterilisation von Glucocorticosteroiden mit überkritischem CO2
FR2898273B1 (fr) * 2006-03-07 2013-11-08 Merck Generiques Procede de sterilisation par chauffage par voie seche d'une poudre comprenant un glucocorticosteroide
US8845962B2 (en) 2011-06-07 2014-09-30 Actitech, L.P. Apparatus and method for steam disinfection of a powder
CN104736158A (zh) 2012-01-23 2015-06-24 萨奇治疗股份有限公司 神经活性类固醇制剂和治疗中枢神经系统障碍的方法
US9498554B2 (en) 2012-07-24 2016-11-22 S.C. Johnson & Son, Inc. Dispensing device
RU2667010C2 (ru) 2012-08-21 2018-09-13 Сейдж Терапьютикс, Инк. Способы лечения эпилепсии или эпилептического статуса
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
MA45276A (fr) * 2015-06-18 2018-04-25 Sage Therapeutics Inc Solutions de stéroïdes neuroactifs et leurs méthodes d'utilisation
JP6838074B2 (ja) 2016-03-08 2021-03-03 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
CN109310701A (zh) * 2016-04-14 2019-02-05 广东东阳光药业有限公司 布地奈德混悬喷雾剂
WO2022231532A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
US4939135A (en) * 1988-10-03 1990-07-03 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
GB9410222D0 (en) 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
GB2291348B (en) 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
US20010051131A1 (en) * 1996-06-19 2001-12-13 Evan C. Unger Methods for delivering bioactive agents
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US20020198174A1 (en) 2001-05-07 2002-12-26 Allergan Sales, Inc. Disinfecting and solubilizing steroid compositions
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
US6852279B2 (en) 2002-06-28 2005-02-08 Ethicon, Inc. Sterilization with temperature-controlled diffusion path
FR2804326B1 (fr) 2000-01-27 2002-10-18 Ellipse Pharmaceuticals Procede de sterilisation par traitement sous hautes pressions de principes actifs sensibles
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009612D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
WO2002007788A1 (en) 2000-07-26 2002-01-31 Jacques Protic A sterilisation process and apparatus therefor
BR0115415A (pt) * 2000-11-15 2003-09-09 Mohan A Chandavarkar Droga de combinação
DK1337279T3 (da) 2000-11-24 2006-09-25 Breath Ltd Sterilisation af glucocorticosteroidsuspensioner
US20030129242A1 (en) * 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
AUPS158502A0 (en) 2002-04-08 2002-05-16 Dermcare-Vet Pty Ltd Allergic dermatitis composition and method of treatment
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient

Also Published As

Publication number Publication date
EP1574222A1 (de) 2005-09-14
US7892483B2 (en) 2011-02-22
EP1574222B1 (de) 2011-02-09
ATE497787T1 (de) 2011-02-15
US20050201888A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
ATE497787T1 (de) Sterilisationsprozess für steroide
WO2006119300A3 (en) Method of using oxidative reductive potential water solution in dental applications
MA33806B1 (fr) Inhibiteurs du virus de l'hepatite c
EA200801698A1 (ru) Лекарственные композиции для применения в вагине
WO2007081401A3 (en) Use of ultraviolet germicidal irradiation in health care environments
BRPI0411142A (pt) método para esterilizar um artigo na cámara de esterilização
DOP2008000001A (es) Oxazolidinonas substituidas y su uso
CY1109420T1 (el) Ενωσεις εστερα ν-αλκυλκαρβονυλ-αμινοξεος και ν-αλκυλκαρβονυλ-αμινο λακτονης και χρηση αυτων
GB0518804D0 (en) Exudialysis tissue cleanser
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
PE20091557A1 (es) Derivados de piridazina y su uso como agentes terapeuticos
NO20065469L (no) Behandling av infeksjonssykdommer.
NO20073437L (no) Innretning og fremgangsmate for identifisering og behandling av vaginale sykdommer
NO20050529L (no) Ciclesonidinneholdende steril vandig suspensjon
DK2022332T3 (da) Vandigt desinfektionsmiddel til nedsættelse af kimtallet i luft
WO2009052090A3 (en) Silicate containing compositions and methods of treatment
WO2017032561A3 (de) Reinigungs- und desinfektionseinrichtung, medizinisches system sowie verfahren zum betreiben einer reinigungs- und desinfektionseinrichtung
EA200970663A1 (ru) Лечение инфекционных болезней
WO2011020597A3 (de) Desinfektionsmittel, dessen verwendung und desinfektionsverfahren
BR0209846B1 (pt) utilizaÇço de um agente obtido pela irradiaÇço uv artificial de uma soluÇço aquosa para tratamento de esterilizaÇço de instrumentos mÉdicos.
CL2011001515A1 (es) Compuestos derivados de fenazopiridina; composicion farmaceutica que los comprende; metodo de preparacion y su uso para tratar el dolor del tracto urinario, ardor, irritacion, malestar o miccion urgente o frecuente causado por infecciones, cirugia, daños o procedimientos de examen del tracto urinario.
WO2008097885A3 (en) Decellularization of soft tissue
AR015761A1 (es) Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedades
CN208591343U (zh) 一种医用电子体温计消毒装置
CN204840418U (zh) 一种吸引器头